Since its inception, we have focused on antibody R&D and production as its core business, and devoted itself to creating and meticulously operating its independent brand — Lamarck.
In the field of antibody R&D, we have established a diversified and comprehensive technology platform, covering multiple cutting-edge directions including rabbit recombinant genetic engineering antibodies, nano genetic engineering antibodies, mouse monoclonal antibodies, and rabbit polyclonal antibodies. The development of each type of antibody embodies the wisdom and painstaking efforts of the R&D team. By virtue of sophisticated professional technologies and rigorous scientific attitudes, the team continuously explores the technical boundaries of antibody R&D and achieves constant breakthroughs and innovations.
After more than 20 years of intensive cultivation and accumulation, relying on its outstanding R&D capabilities and stringent quality control system, we have successfully built a rich and diverse product portfolio. At present, we owns more than 30,000 types of antibodies and related products with an extremely complete product range: it not only covers a wide variety of antibody products to precisely meet the differentiated needs of different scientific research scenarios; but also launches high-sensitivity and high-accuracy ELISA Kits, providing convenient and reliable detection tools for researchers; furthermore, it has innovatively developed mIHC/Multiplex Fluorescence Detection Kits to help researchers achieve accurate analysis of complex biological samples; meanwhile, it supplies supporting molecular and cell-related products, forming a one-stop scientific research solution.
With innovation as its core driving force and quality as the cornerstone of development, we are committed to providing high-quality and efficient antibodies and related products for the global scientific research community, and continuously promoting the innovative breakthroughs and sustainable development of life science research.
Directly conjugated primary antibodies for IF streamline workflows, reduce background, enable multiplex staining, and expand special sample applications, enhancing IF efficiency, accuracy and flexibility.
Directly conjugated antibodies for FCM simplify workflows, reduce background signals, optimize multiplex analysis, and enhance experimental reproducibility, significantly improving FCM detection efficiency, accuracy and flexibility.
Primary Antibodies, Secondary Antibodies, mIHC Kits, ELISA Kits, Proteins, Molecular Biology Products,Cell Lines,Reagents ...
Contact Us